| Name | Title | Contact Details |
|---|
Alnylam is the world`s leading RNAi therapeutics company and the first and only company to bring an RNAi medicine to market. We are developing RNAi (RNA interference) as an innovative, entirely new class of medicines to treat rare genetic, cardio metabolic, acute hepatic infectious and central nervous system (CNS) and ocular diseases. Alnylam was founded in 2002 based on a Nobel Prize-winning breakthrough in biology – the discovery of RNAi, and a bold vision that this discovery could be used to silence disease-causing genes upstream of today`s medicines. We are relentless in our pursuit of new treatments because we believe that RNAi therapeutics can be used to treat many diseases for which treatment options do not exist or are inadequate. Overall, we believe that patients shouldn`t have to wait for hope. Alnylam is turning scientific possibility into reality - in 2018, the FDA and European EMA approved of our first product, ONPATTRO (patisiran) which is also the first-ever approved RNAi therapeutic. In 2019, the FDA approved our second product, GIVLAARI (givosiran). Our robust pipeline of investigational medicines includes multiple programs in late-stage and early-stage clinical development. We are a global and diverse company of more than 1,500 people. We pride ourself on fostering a fun, inclusive and dynamic work environment where employees can recognize their fullest potential. That`s why we`ve been named a Science Magazine Top Employer for two years in a row (`19-`20), a Boston Globe Top Place to Work 5x in a row (`15-`19) and one of Fast Company`s 50 Most Innovative Companies for 2019. We are based in Cambridge, U.S., with offices throughout Europe, Asia and South America.
Driven by a vision to liberate patients from degenerative disease, BlueRock Therapeutics is ushering in a new era of cell-based medicines. Founded in 2016, BlueRock and its team of preeminent scientists are pioneering cell therapies that restore critical natural functions in the body, with an initial focus on severe brain and heart conditions. BlueRock`s culture is defined by scientific transparency, the highest ethical standards and an urgency to bring transformative treatments to all who would benefit.
Bethesda Gardens At Fort Worth is a Fort Worth, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
PresenceLearning is the leading provider of online special education services for early intervention and K-12 students in the United States. We provide “anytime, anywhere” access to a network of more than 700 fully licensed, highly qualified clinicians who work face-to-face with students via live videoconferencing using our proprietary platform and instructional activities. Since our founding in 2009, we have delivered more than 1,000,000 sessions of teletherapy to hundreds of school districts, charter schools, and virtual school organizations across the United States. And we`re not stopping there. The shortage of Speech-Language Pathologists (SLPs), Occupational Therapists (OTs), and Mental Health Professionals (MHPs) is reaching crisis proportions, innovative modes of delivery have become essential for providing access to therapeutic services. Our dedicated team of employees is committed to seeing children thrive via the growing online therapy revolution.
Palisades Medical Center is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Palisades Medical Center is based in North Bergen, NJ. You can find more information on Palisades Medical Center at www.palisadesmedical.org